Brett A. Pletcher

Companies

• CytokineticsGeneral counsel Aug 19, 2024 to Sep 3, 2024¹
• Gilead SciencesEVP, Gen Counsel & Corp Sec May 16, 2018 to Jun 13, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• GSGilead Sciences GILD33,426 shares³$5.2M at $156.25Jun 10, 2022
• CCytokinetics CYTK33,140 shares⁴$2.1M at $62.76Aug 30, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 30, 2024Granted 33,140 shares of Cytokinetics⁴
• Jun 10, 2022Shares withheld for tax 280 shares at $60.74 of Gilead Sciences³
• Jun 10, 2022Exercised options 782 shares of Gilead Sciences³
• Mar 11, 2022Sold 3,634 shares at $58.24 of Gilead Sciences⁵
• Mar 10, 2022Shares withheld for tax 2,089 shares at $57.92 of Gilead Sciences⁵
• Mar 10, 2022Exercised options 3,130 shares of Gilead Sciences⁵
• Mar 10, 2022Exercised options 2,593 shares of Gilead Sciences⁵
• Feb 15, 2022Granted 348 shares at $52.13 of Gilead Sciences⁶
• Feb 9, 2022Sold 1,691 shares at $63.89 of Gilead Sciences⁷
• Feb 6, 2022Shares withheld for tax 1,036 shares at $63.90 of Gilead Sciences⁸
• Feb 6, 2022Exercised options 2,727 shares of Gilead Sciences⁸
• Feb 1, 2022Sold 14,061 shares at $68.54 of Gilead Sciences⁹
• Jan 26, 2022Shares withheld for tax 5,681 shares at $67.34 of Gilead Sciences¹⁰
• Jan 26, 2022Granted 19,742 shares of Gilead Sciences¹⁰
• Jan 26, 2022Granted 15,262 shares of Gilead Sciences¹⁰